It’s really interesting to see how many of the wearables market companies in this Sweet Sixteen competition are developing technology that fills a medical need. Playtabase’s gesture control band is tackling this market head on based on the co-founder’s experience with a family member’s stroke. Thalmic Labs is more about pushing the boundaries of gaming across everyday life from actually playing games to doing a power point presentation or changing channels on a TV.
Although Thalmic Labs has not explicitly articulated a medical need for its device, it has made its API available to developers, which could lead to lots of different uses for the technology that could very well focus on specific patient populations.
This is something of a David and Goliath matchup. Although both companies are gearing up for 2014 product launches, Thalmic Labs has a big group of high-profile backers like First Round Capital and Intel Labs as well as at least 21 private investors.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
The Myo senses the electrical activity from your muscles to control Bluetooth connected devices. Playtabase does something similar but focuses more on open home automation systems. Additionally, reemo lets users control traditional binary electronics such as lamps and fans.
Muhammad Abdurrahman CEO of Playtabase developed the company’s reemo gesture control device after his father suffered a series of strokes. Stephen Lake, Matthew Bailey, and Aaron Grant studied mechanical engineering together at the University of Waterloo.
Thalmic Labs has priced its device at $150 and Playtabase has said it expects to price its device in the $100-$200 range.
Winner: Playtabase
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Why? This was really close. Myo has the potential to affect many more people, especially since it’s made its API available to developers. But one of the great things about March Madness are the Cinderella stories that emerge. Playtabase’s reemo scored a 3 pointer with seconds remaining.
